Innovation and Collaboration Program
The Lustgarten Foundation’s Innovation and Collaboration Program provides seed funding for investigators who have highly innovative research with significant potential to accelerate the mission to transform pancreatic cancer into a curable disease. Each recipient is awarded a one-year, $110,000 grant for their pancreatic cancer research.
2022 Recipients
Mandar Muzumndar, MD, Co-Director of Pancreas Program, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yake Cancer Center, for his study “Dietary Oleic Acid Reprograms Pancreatic Lipid Metabolism to Drive Cancer Development.”
Andrew Lowy, MD, Director of Surgical Oncology at UC San Diego and Associate Director, Moores Cancer Center, for his study “Building on KRAS Inhibition in Pancreas Cancer: Defining Rational Pairings to Combat Resistance and Enhance Responses to Immunotherapy.”
